Neural correlates of audiovisual motion capture

Visual motion can affect the perceived direction of auditory motion (i.e., audiovisual motion capture). It is debated, though, whether this effect occurs at perceptual or decisional stages. Here, we examined the neural consequences of audiovisual motion capture using the mismatch negativity (MMN), an event-related brain potential reflecting pre-attentive auditory deviance detection. In an auditory-only condition occasional changes in the direction of a moving sound (deviant) elicited an MMN starting around 150 ms. In an audiovisual condition, auditory standards and deviants were synchronized with a visual stimulus that moved in the same direction as the auditory standards. These audiovisual deviants did not evoke an MMN, indicating that visual motion reduced the perceptual difference between sound motion of standards and deviants. The inhibition of the MMN by visual motion provides evidence that auditory and visual motion signals are integrated at early sensory processing stages

FAIR environmental and health registry (FAIREHR)- supporting the science to policy interface and life science research, development and innovation

Funding Information: Most co-authors were financialy supported with their respective inistitution. Some of the co-authors were financialy supportrd by the “Safe and Efficient Chemistry by Design (SafeChem)” project (grant no. DIA 2018/11) funded by the Swedish Foundation for Strategic Environmental Research, and by the PARC project (grant no. 101057014) funded under the European Union’s Horizon Europe Research and Innovation program. Publisher Copyright: Copyright © 2023 Zare Jeddi, Galea, Viegas, Fantke, Louro, Theunis, Govarts, Denys, Fillol, Rambaud, Kolossa-Gehring, Santonen, van der Voet, Ghosh, Costa, Teixeira, Verhagen, Duca, Van Nieuwenhuyse, Jones, Sams, Sepai, Tranfo, Bakker, Palmen, van Klaveren, Scheepers, Paini, Canova, von Goetz, Katsonouri, Karakitsios, Sarigiannis, Bessems, Machera, Harrad and Hopf.The environmental impact on health is an inevitable by-product of human activity. Environmental health sciences is a multidisciplinary field addressing complex issues on how people are exposed to hazardous chemicals that can potentially affect adversely the health of present and future generations. Exposure sciences and environmental epidemiology are becoming increasingly data-driven and their efficiency and effectiveness can significantly improve by implementing the FAIR (findable, accessible, interoperable, reusable) principles for scientific data management and stewardship. This will enable data integration, interoperability and (re)use while also facilitating the use of new and powerful analytical tools such as artificial intelligence and machine learning in the benefit of public health policy, and research, development and innovation (RDI). Early research planning is critical to ensuring data is FAIR at the outset. This entails a well-informed and planned strategy concerning the identification of appropriate data and metadata to be gathered, along with established procedures for their collection, documentation, and management. Furthermore, suitable approaches must be implemented to evaluate and ensure the quality of the data. Therefore, the ‘Europe Regional Chapter of the International Society of Exposure Science’ (ISES Europe) human biomonitoring working group (ISES Europe HBM WG) proposes the development of a FAIR Environment and health registry (FAIREHR) (hereafter FAIREHR). FAIR Environment and health registry offers preregistration of studies on exposure sciences and environmental epidemiology using HBM (as a starting point) across all areas of environmental and occupational health globally. The registry is proposed to receive a dedicated web-based interface, to be electronically searchable and to be available to all relevant data providers, users and stakeholders. Planned Human biomonitoring studies would ideally be registered before formal recruitment of study participants. The resulting FAIREHR would contain public records of metadata such as study design, data management, an audit trail of major changes to planned methods, details of when the study will be completed, and links to resulting publications and data repositories when provided by the authors. The FAIREHR would function as an integrated platform designed to cater to the needs of scientists, companies, publishers, and policymakers by providing user-friendly features. The implementation of FAIREHR is expected to yield significant benefits in terms of enabling more effective utilization of human biomonitoring (HBM) data.publishersversionpublishe

FAIR environmental and health registry (FAIREHR)- supporting the science to policy interface and life science research, development and innovation

The environmental impact on health is an inevitable by-product of human activity. Environmental health sciences is a multidisciplinary field addressing complex issues on how people are exposed to hazardous chemicals that can potentially affect adversely the health of present and future generations. Exposure sciences and environmental epidemiology are becoming increasingly data-driven and their efficiency and effectiveness can significantly improve by implementing the FAIR (findable, accessible, interoperable, reusable) principles for scientific data management and stewardship. This will enable data integration, interoperability and (re)use while also facilitating the use of new and powerful analytical tools such as artificial intelligence and machine learning in the benefit of public health policy, and research, development and innovation (RDI). Early research planning is critical to ensuring data is FAIR at the outset. This entails a well-informed and planned strategy concerning the identification of appropriate data and metadata to be gathered, along with established procedures for their collection, documentation, and management. Furthermore, suitable approaches must be implemented to evaluate and ensure the quality of the data. Therefore, the 'Europe Regional Chapter of the International Society of Exposure Science' (ISES Europe) human biomonitoring working group (ISES Europe HBM WG) proposes the development of a FAIR Environment and health registry (FAIREHR) (hereafter FAIREHR). FAIR Environment and health registry offers preregistration of studies on exposure sciences and environmental epidemiology using HBM (as a starting point) across all areas of environmental and occupational health globally. The registry is proposed to receive a dedicated web-based interface, to be electronically searchable and to be available to all relevant data providers, users and stakeholders. Planned Human biomonitoring studies would ideally be registered before formal recruitment of study participants. The resulting FAIREHR would contain public records of metadata such as study design, data management, an audit trail of major changes to planned methods, details of when the study will be completed, and links to resulting publications and data repositories when provided by the authors. The FAIREHR would function as an integrated platform designed to cater to the needs of scientists, companies, publishers, and policymakers by providing user-friendly features. The implementation of FAIREHR is expected to yield significant benefits in terms of enabling more effective utilization of human biomonitoring (HBM) data.PARC project (grant no. 101057014) funded under the European Union’s Horizon Europe Research and Innovation program.info:eu-repo/semantics/publishedVersio

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016) : part two

Background The immunological escape of tumors represents one of the main ob- stacles to the treatment of malignancies. The blockade of PD-1 or CTLA-4 receptors represented a milestone in the history of immunotherapy. However, immune checkpoint inhibitors seem to be effective in specific cohorts of patients. It has been proposed that their efficacy relies on the presence of an immunological response. Thus, we hypothesized that disruption of the PD-L1/PD-1 axis would synergize with our oncolytic vaccine platform PeptiCRAd. Methods We used murine B16OVA in vivo tumor models and flow cytometry analysis to investigate the immunological background. Results First, we found that high-burden B16OVA tumors were refractory to combination immunotherapy. However, with a more aggressive schedule, tumors with a lower burden were more susceptible to the combination of PeptiCRAd and PD-L1 blockade. The therapy signifi- cantly increased the median survival of mice (Fig. 7). Interestingly, the reduced growth of contralaterally injected B16F10 cells sug- gested the presence of a long lasting immunological memory also against non-targeted antigens. Concerning the functional state of tumor infiltrating lymphocytes (TILs), we found that all the immune therapies would enhance the percentage of activated (PD-1pos TIM- 3neg) T lymphocytes and reduce the amount of exhausted (PD-1pos TIM-3pos) cells compared to placebo. As expected, we found that PeptiCRAd monotherapy could increase the number of antigen spe- cific CD8+ T cells compared to other treatments. However, only the combination with PD-L1 blockade could significantly increase the ra- tio between activated and exhausted pentamer positive cells (p= 0.0058), suggesting that by disrupting the PD-1/PD-L1 axis we could decrease the amount of dysfunctional antigen specific T cells. We ob- served that the anatomical location deeply influenced the state of CD4+ and CD8+ T lymphocytes. In fact, TIM-3 expression was in- creased by 2 fold on TILs compared to splenic and lymphoid T cells. In the CD8+ compartment, the expression of PD-1 on the surface seemed to be restricted to the tumor micro-environment, while CD4 + T cells had a high expression of PD-1 also in lymphoid organs. Interestingly, we found that the levels of PD-1 were significantly higher on CD8+ T cells than on CD4+ T cells into the tumor micro- environment (p < 0.0001). Conclusions In conclusion, we demonstrated that the efficacy of immune check- point inhibitors might be strongly enhanced by their combination with cancer vaccines. PeptiCRAd was able to increase the number of antigen-specific T cells and PD-L1 blockade prevented their exhaus- tion, resulting in long-lasting immunological memory and increased median survival

Electronic conduction in elongated molecular dyads containing a constrained bridge

EThOS - Electronic Theses Online ServiceGBUnited Kingdo

Sodium Selenate Fertilisation Increases Selenium Accumulation and Decreases Glucosinolate Concentration in Rapid-cycling \u3cem\u3eBrassica Oleracea\u3c/em\u3e

Glucosinolates (GSs) are S-containing compounds found in Brassica species and whose degradation products may provide protection against cancer. Sulphoraphane, a product of 4-methylsulphinylbutyl GS degradation, is a particularly potent inhibitor of anticarcinogenic detoxification enzymes. Selenium also has anticancer properties, and consumption of plants containing Se may be an effective way to increase dietary Se. Since plant uptake of Se and S is competitive, GS synthesis may be affected by Se fertilisation. The objective of this study was to determine how Se fertilisation of rapid-cycling B oleracea would affect Se and GS concentrations. Plants were grown in hydroponic solutions containing 0.0, 1.0, 2.0, 3.0, 6.0, 7.2 or 9.0 mg l−1 Na2SeO4. Mineral and glucosinolate concentrations were measured in shoots harvested just before anthesis. Total GSs decreased from 5.84 µmol g−1 (0.0 mg l−1 Na2SeO4) to 1.90 µmol g−1 (9.0 mg l−1Na2SeO4). Levels of 4-methylsulphinylbutyl GS decreased 90% when Na2SeO4 fertilisation was increased from 0 to 1 mg l−1, and remained low at higher Na2SeO4 concentrations. Shoot Se concentration was undetectable at 0.0 mg l−1 Na2SeO4 and increased significantly with Na2SeO4 fertilisation. Although B oleracea may not simultaneously deliver high levels of dietary 4-methylsulphinylbutyl GS and Se, levels of other GSs with anticarcinogenic benefits may be beneficial even with Se fertilisation

TOWARD A COMPLETE EQUILIBRIUM STRUCTURE OF BUTADIENE; HIGH-RESOLUTION INFRARED SPEC-TROSCOPY OF BUTADIENE-1-13C1^{13}C_{1}

$^{a}$W. Caminati, G. Grassi, and A. Bauder Chem. Phys. Letters 148, 13, (1988). $^{b}$N. C. Craig, J. L. Davis, K. A. Hanson, M. C. Moore, and M. Lock J. Mol. Struct. 00, 000, (2004). $^{c}$N. C. Craig, K. A. Hanson, R. W. Pierce, S. D. Saylor, and R. L. Sams J. Mol. Spectrosc., submitted. $^{d}$P. Huber-W\""{a}lchli and Hs. H. G\""{u}nthard Spectrochim. Acta, 37A, 285, (1981); Yu. N. Panchenko, private communication.Author Institution: Department of Chemistry, Oberlin College; Department of Chemistry, Pacific Northwest National LaboratoryConsiderable progress has been made toward obtaining ground state rotational constants for butadiene (BDE) and its isotopomers for use in fitting an equilibrium structure. With the exception of a microwave investigation of the weakly polar BDE-$1,1-d_{2},{^{a}}$ studies of all of the other, nonpolar species have been done with high-resolution ($0.002 cm^{-1}$) infrared spectroscopy. Rotational constants are available for BDE and BDE$-2,3-d_{2}$ from one $study^{b}$ and for the three species of BDE$-1,4-d_{2}$ from another $study.^{c}$ The present report is on BDE$-1-^{13}C_{1}$. The rotational structure in the C-type bands at $524 cm^{-1}, 900 cm^{-1}$, and $908 cm^{-1}$ in the infrared spectrum has been analyzed. Rotational constants fit to 2191 ground state combination differences derived from all three bands are (in $cm^{-1}$) A = 1.3887919 (6), B = 0.1436683 (3), and C = 0.1302251 (3). In the parent molecule of $C_{2h}$ symmetry, a Raman-active $b_{g}$ mode occurs at $908 cm^{-1}$ and an infrared-active mode occurs at essentially the same frequency. In BDE$-1-^{13}C_{1}$ of reduced, $C_{s}$ symmetry, both modes have significant infrared intensity and occur at 908 and $900 cm^{-1}$. The higher frequency mode is $CH_{2}$ flapping; the lower frequency one is $^{13}CH_{2}$ flapping. $^{d}